Nucleic acid aptamers are peptides or oligonucleotide molecules that bond with a particular target molecule. They are a specific class of nucleic acid created via rounds of in-vitro selection or SELEX (systematic evolution of ligands by exponential enrichment).
The unique applications of nucleic acid aptamers and their expanding properties across various sectors is fueling the nucleic acid aptamers market growth. Aptamers are being explored in drug delivery systems, personalized medicines, biomarker discovery, and biosensors.
They have the ability to bind to small molecules, proteins, and even cells, tissues, and organisms, which opens up numerous possibilities in biotechnology and healthcare.
The overall nucleic acid aptamers market is growing. Companies in this sector are actively engaging in partnerships and collaborations to gain a strong foothold in the market.
Nucleic acid aptamers are not only distinctly recognizable, they also offer advantages over antibodies, such as the possibility to be synthesized completely in a test tube, have desirable storage properties, and extremely little immunogenicity in therapeutic applications such as drug delivery, and anti-viral therapy.
Nucleic acid aptamers are used for their high specificity for their targets, comparable to antibodies. It also provides molecular recognition of certain characters that fight antibodies and as a result, are quickly emerging as a possible alternative to commonly used biomolecules and antibodies.
Recent advancements in generation, purification, and drug delivery for killing target cells have attracted the attention of various researchers toward aptamers due to the competitive advantages associated with them.
The surge in awareness of the significance of aptamers over antibodies along with technological growth and support from the rising disease spectrum are the key factors driving the nucleic acid aptamers market demand.
| Attribute | Detail |
|---|---|
| Drivers |
|
As research progresses, new and more effective nucleic acid aptamers are being discovered. These developments increase the range of possible uses for aptamers in biotechnology, medicine, and diagnostics.
For instance, in March 2024, Professor Yohei Yamauchi, from the Institute of Pharmaceutical Sciences (IPW) at ETH Zurich, Switzerland, and TAGCyx Biotechnologies Inc., a preclinical stage start-up biotechnology company based in Tokyo, Japan, announced a strategic research collaboration.
The collaboration aims to discover and develop novel Xenoligo aptamers targeting specific infectious disease agents. TAGCyx will leverage its proprietary Xenoligo platform, which features artificial base-containing DNA aptamers to identify aptamers with high affinity and specificity.
These aptamers will be evaluated by Professor Yamauchi's team at ETH Zurich for their efficacy in disrupting viral infectivity.
The surge in prevalence of chronic and infectious diseases is anticipated to drive the nucleic acid aptamer market growth during the forecast period. Chronic diseases such as cancer, diabetes, and cardiovascular diseases, as well as infectious diseases including HIV, hepatitis, and emerging viral infections, require precise and early diagnosis for effective treatment.
Nucleic acid aptamers market, with their high specificity and affinity for target molecules, are being developed for use in advanced diagnostic assays that can detect diseases at earlier stages with greater accuracy.
Data published by Centers for Disease Control and Prevention in June 2024, estimates that so far this flu season there have been at least 35 million illnesses, 390,000 hospitalizations, and 25,000 deaths in the U.S. in 2023.
Flu season typically occurs in the fall and winter, peaking between December and February, though it can start as early as October and extend into May.
Moreover, according to data published by American Cancer Society in 2024, 1,958,310 new cancer cases and 609,820 cancer occurred in the U.S. in 2023.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the nucleic acid aptamers market analysis, North America dominates the landscape. The U.S. is a hub of biotechnology and pharmaceutical innovation.
Furthermore, significant investments in research and development in the region have propelled advancements in aptamer technology, including improved selection methods, enhanced binding affinities, and novel applications in drug delivery and diagnostics.
Regulatory bodies such as the FDA in the U.S. play a vital role in shaping the nucleic acid aptamer market, providing guidance and approval pathways for aptamer-based products, ensuring safety, efficacy, and compliance with regulatory standards. This boosts nucleic acid aptamers market value and commercialization.
Moreover, various product approvals associated with ophthalmology are expected to drive market progress in North America. For instance, in August 2023, FDA approved the second RNA aptamer, Izervay for treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
The drug was earlier known as Zimura and has been developed by Iveric Bio (acquired by Astellas in July 2023). The drug was launched in the U.S. in September 2023 and achieved sales of US$ 0.03 billion in the first nine months of 2023.
The global nucleic acid aptamers market share is fragmented with the presence of a large number of players. Aptagen Labs, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology Inc., Aptamer Sciences, Inc., SomaLogic Operating Co., Inc., AptaTargets SL., and Aptus Biotech S.L. are the prominent nucleic acid aptamers industry manufacturers.
Key players have been profiled in the nucleic acid aptamers market research report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 219.9 Mn |
| Forecast Value in 2034 | More than US$ 1.2 Bn |
| CAGR | 17.2% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 219.9 Mn in 2023
It is projected to reach more than US$ 1.2 Bn by the end of 2034
The CAGR is anticipated to be 17.2% from 2024 to 2034
North America is expected to account for the largest share from 2024 to 2034
Aptagen Labs, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology Inc., Aptamer Sciences, Inc., SomaLogic Operating Co., Inc., AptaTargets SL., and Aptus Biotech S.L.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nucleic Acid Aptamers Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nucleic Acid Aptamers Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. PORTERs Five Forces Analysis
5.3. Value Chain Analysis
6. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type, 2020-2034
6.3.1. DNA Aptamer
6.3.2. RNA Aptamer
6.3.3. XNA Aptamer
6.4. Market Attractiveness By Type
7. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Drug Delivery
7.3.2. Anti-viral Therapy
7.3.3. Pathogen Recognition
7.3.4. Disease Recognition
7.3.5. Stem Cell Markers
7.3.6. Others
7.4. Market Attractiveness By Application
8. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Indication, 2020-2034
8.3.1. Viral infection
8.3.2. Cancer
8.3.3. Ophthalmology
8.3.4. Others
8.4. Market Attractiveness By Indication
9. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Biopharmaceutical Companies
9.3.2. Diagnostic Centers
9.3.3. CROs
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Nucleic Acid Aptamers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2020-2034
11.2.1. DNA Aptamer
11.2.2. RNA Aptamer
11.2.3. XNA Aptamer
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Drug-Delivery
11.3.2. Anti-viral Therapy
11.3.3. Pathogen Recognition
11.3.4. Disease Recognition
11.3.5. Stem Cell Markers
11.3.6. Others
11.4. Market Value Forecast By Indication, 2020-2034
11.4.1. Viral infection
11.4.2. Cancer
11.4.3. Ophthalmology
11.4.4. Others
11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Biopharmaceutical Companies
11.5.2. Diagnostic Centers
11.5.3. CROs
11.5.4. Others
11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Nucleic Acid Aptamers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2020-2034
12.2.1. DNA Aptamer
12.2.2. RNA Aptamer
12.2.3. XNA Aptamer
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Drug-Delivery
12.3.2. Anti-viral Therapy
12.3.3. Pathogen Recognition
12.3.4. Disease Recognition
12.3.5. Stem Cell Markers
12.3.6. Others
12.4. Market Value Forecast By Indication, 2020-2034
12.4.1. Viral infection
12.4.2. Cancer
12.4.3. Ophthalmology
12.4.4. Others
12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Biopharmaceutical Companies
12.5.2. Diagnostic Centers
12.5.3. CROs
12.5.4. Others
12.6. Market Value Forecast By Country/Sub-region, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By Indication
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Nucleic Acid Aptamers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2020-2034
13.2.1. DNA Aptamer
13.2.2. RNA Aptamer
13.2.3. XNA Aptamer
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Drug-Delivery
13.3.2. Anti-viral Therapy
13.3.3. Pathogen Recognition
13.3.4. Disease Recognition
13.3.5. Stem Cell Markers
13.3.6. Others
13.4. Market Value Forecast By Indication, 2020-2034
13.4.1. Viral infection
13.4.2. Cancer
13.4.3. Ophthalmology
13.4.4. Others
13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Biopharmaceutical Companies
13.5.2. Diagnostic Centers
13.5.3. CROs
13.5.4. Others
13.6. Market Value Forecast By Country/Sub-region, 2020-2034
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By Indication
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Nucleic Acid Aptamers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2020-2034
14.2.1. DNA Aptamer
14.2.2. RNA Aptamer
14.2.3. XNA Aptamer
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Drug-Delivery
14.3.2. Anti-viral Therapy
14.3.3. Pathogen Recognition
14.3.4. Disease Recognition
14.3.5. Stem Cell Markers
14.3.6. Others
14.4. Market Value Forecast By Indication, 2020-2034
14.4.1. Viral infection
14.4.2. Cancer
14.4.3. Ophthalmology
14.4.4. Others
14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Biopharmaceutical Companies
14.5.2. Diagnostic Centers
14.5.3. CROs
14.5.4. Others
14.6. Market Value Forecast By Country/Sub-region, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By Indication
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Nucleic Acid Aptamers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type, 2020-2034
15.2.1. DNA Aptamer
15.2.2. RNA Aptamer
15.2.3. XNA Aptamer
15.3. Market Value Forecast By Application, 2020-2034
15.3.1. Drug-Delivery
15.3.2. Anti-viral Therapy
15.3.3. Pathogen Recognition
15.3.4. Disease Recognition
15.3.5. Stem Cell Markers
15.3.6. Others
15.4. Market Value Forecast By Indication, 2020-2034
15.4.1. Viral infection
15.4.2. Cancer
15.4.3. Ophthalmology
15.4.4. Others
15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Biopharmaceutical Companies
15.5.2. Diagnostic Centers
15.5.3. CROs
15.5.4. Others
15.6. Market Value Forecast By Country/Sub-region, 2020-2034
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Application
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Aptagen Labs
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Aptamer Group
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. Base Pair Biotechnologies
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. NeoVentures Biotechnology Inc.
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. Aptamer Sciences, Inc.
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. SomaLogic Operating Co., Inc.
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. AptaTargets SL.
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments
16.2.8. Aptus Biotech S.L.
16.2.8.1. Company Overview
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Business Strategies
16.2.8.5. Recent Developments
16.2.9. Other Prominent Players
16.2.9.1. Company Overview
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Business Strategies
16.2.9.5. Recent Developments
List of Tables
Table 01: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 02: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 04: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
Table 05: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 06: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 07: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 08: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 09: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 10: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
Table 11: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 13: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 14: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 15: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
Table 16: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 18: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 19: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
Table 21: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 23: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 25: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
Table 26: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 28: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 29: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 30: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users,
List of Figures
Figure 01: Nucleic Acid Aptamers Market Size, by Type, 2023
Figure 02: Nucleic Acid Aptamers Market share (%), by Type, 2023
Figure 03: Nucleic Acid Aptamers Market Size, by Application, 2023
Figure 04: Nucleic Acid Aptamers Market share (%), by Application, 2023
Figure 05: Nucleic Acid Aptamers Market Size, by Indication, 2023
Figure 06: Nucleic Acid Aptamers Market share (%), by Application, 2023
Figure 07: Nucleic Acid Aptamers Market Size, by End-users, 2023
Figure 08: Nucleic Acid Aptamers Market share (%), by End-users, 2023
Figure 09: Global Nucleic Acid Aptamers Market, By Region (2023 and 2034)
Figure 10: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, 2020-2034
Figure 11: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 12: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023
Figure 13: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2034
Figure 14: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 15: Global Nucleic Acid Aptamers Market Value (US$ Mn), by DNA Aptamer, 2020-2034
Figure 16: Global Nucleic Acid Aptamers Market Value Share Analysis, by DNA Aptamer, 2023 and 2034
Figure 17: Global Nucleic Acid Aptamers Market Value (US$ Mn), by RNA Aptamer, 2020-2034
Figure 18: Global Nucleic Acid Aptamers Market Value Share Analysis, RNA Aptamer, 2023 and 2034
Figure 19: Global Nucleic Acid Aptamers Market Value (US$ Mn), by XNA Aptamer, 2020-2034
Figure 20: Global Nucleic Acid Aptamers Market Value Share Analysis, by XNA Aptamer, 2023 and 2034
Figure 21: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 22: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023
Figure 23: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2034
Figure 24: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 25: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Drug-Delivery, 2020-2034
Figure 26: Global Nucleic Acid Aptamers Market Value Share Analysis, by Drug-Delivery, 2023 and 2034
Figure 27: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Anti-Viral Therapy, 2020-2034
Figure 28: Global Nucleic Acid Aptamers Market Value Share Analysis, Anti-Viral Therapy, 2023 and 2034
Figure 29: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Pathogen Recognition, 2020-2034
Figure 30: Global Nucleic Acid Aptamers Market Value Share Analysis, by Pathogen Recognition, 2023 and 2034
Figure 31: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Disease Recognition, 2020-2034
Figure 32: Global Nucleic Acid Aptamers Market Value Share Analysis, Disease Recognition, 2023 and 2034
Figure 33: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Stem Cell Markers, 2020-2034
Figure 34: Global Nucleic Acid Aptamers Market Value Share Analysis, by Stem Cell Markers, 2023 and 2034
Figure 35: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
Figure 36: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
Figure 37: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 38: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023
Figure 39: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2034
Figure 40: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 41: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Viral Infection, 2020-2034
Figure 42: Global Nucleic Acid Aptamers Market Value Share Analysis, by Viral Infection, 2023 and 2034
Figure 43: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Cancer, 2020-2034
Figure 44: Global Nucleic Acid Aptamers Market Value Share Analysis, Cancer, 2023 and 2034
Figure 45: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Ophthalmology, 2020-2034
Figure 46: Global Nucleic Acid Aptamers Market Value Share Analysis, by Ophthalmology, 2023 and 2034
Figure 47: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
Figure 48: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
Figure 49: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 50: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023
Figure 51: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2034
Figure 52: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Figure 53: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Biopharmaceutical Companies, 2020-2034
Figure 54: Global Nucleic Acid Aptamers Market Value Share Analysis, by Biopharmaceutical Companies, 2023 and 2034
Figure 55: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Diagnostic Centers, 2020-2034
Figure 56: Global Nucleic Acid Aptamers Market Value Share Analysis, Diagnostic Centers, 2023 and 2034
Figure 57: Global Nucleic Acid Aptamers Market Value (US$ Mn), by CROs, 2020-2034
Figure 58: Global Nucleic Acid Aptamers Market Value Share Analysis, by CROs, 2023 and 2034
Figure 59: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
Figure 60: Global Nucleic Acid Aptamers Market Value Share Analysis, Hospitals, 2023 and 2034
Figure 61: Global Nucleic Acid Aptamers Market Value Share Analysis, by Region, 2023 and 2034
Figure 62: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Region, 2023-2034
Figure 63: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 64: North America Nucleic Acid Aptamers Market Value Share Analysis, by Country, 2023 and 2034
Figure 65: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country, 2023-2034
Figure 66: North America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 67: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 68: North America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 69: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 70: North America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 71: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 72: North America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 73: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Figure 74: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 75: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 76: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 77: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 78: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 79: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 80: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 81: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 82: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 83: Europe Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 84: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Figure 85: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 86: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 87: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 88: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 89: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 90: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 91: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 92: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 93: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 94: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 95: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Figure 96: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 97: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 98: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 99: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 100: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 101: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 102: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 103: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 104: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 105: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 106: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Figure 107: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 108: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 109: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 110: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
Figure 111: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
Figure 112: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
Figure 113: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
Figure 114: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
Figure 115: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
Figure 116: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
Figure 117: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Nucleic Acid Aptamers Market
